Medicine News and Research

RSS

PHARMABIZ.com examines India’s push for clearer definition of counterfeit, substandard medicines

India has taken the lead to get together a number of generic drug-producing nations to call for better definitions to ensure quality, strengthening of regulatory authorities in the respective countries, and bringing focus of the world to public health instead of intellectual property, PHARMABIZ.com writes in an article that examines the recent meeting of leaders from Brazil, India and South Africa on issues regarding counterfeit medicines.

29 Oct 2010

New noninvasive stool DNA test to predict colorectal cancer

An investigational DNA methylation test could alter the screening landscape for colorectal cancer, according to data presented at the American Association for Cancer Research special conference on Colorectal Cancer: Biology to Therapy, held here Oct. 27-30, 2010.

29 Oct 2010

StemCells initiates HuCNS-SC second clinical trial for Batten disease in children

StemCells, Inc. announced today that it has initiated a second clinical trial of its HuCNS-SC product candidate (purified human neural stem cells) in neuronal ceroid lipofuscinosis (NCL, also often referred to as Batten disease), a fatal neurodegenerative disorder in children.

29 Oct 2010

Researchers depict new statistical algorithm to identify genetic variations for common diseases

A group of researchers at The Scripps Research Institute and the Scripps Translational Science Institute has published a paper that reviews new strategies for identifying collections of rare genetic variations that reveal whether people are predisposed to developing common conditions like diabetes and cancer.

29 Oct 2010

More details of the health law revealed as implementation unfolds

The law imposes stringent restrictions on physician-owned hospitals, which critics say cherry pick the lucrative specialty patients community hospitals depend on to stay afloat, Kaiser Health News/USA Today report.

29 Oct 2010

Long hours and nights on call lead to surgeon distress

Just as with everyone else perhaps, the more hours surgeons work, and the more nights they spend on call each week, the more likely they are to face burn-out, depression, dissatisfaction with their careers and serious work-home conflicts, according to a major new study led by Johns Hopkins and Mayo Clinic researchers.

29 Oct 2010

Researchers find link between telomere length and colorectal cancer risk

For the first time, researchers have found a link between long telomeres and an increased risk for colorectal cancer, according to research presented at the American Association for Cancer Research special conference on Colorectal Cancer Biology to Therapy, held here Oct. 27-30, 2010.

29 Oct 2010

Amira initiates AM152 Phase 1 clinical study for fibrotic diseases

Amira Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 clinical study with AM152, a novel LPA1 antagonist, in normal, healthy subjects.

29 Oct 2010

Neurocrine third quarter revenue increases from $0.7 million to $14.4 million

Neurocrine Biosciences, Inc. today announced its financial results for the quarter ended September 30, 2010.

29 Oct 2010

Slivers of frozen ovaries allow for childbirth later in life

According a US fertility expert, young women should freeze parts of their ovaries if they want to postpone motherhood until later in life. This advice came from Dr Sherman Silber at the American Society for Reproductive Medicine meeting in Denver.

28 Oct 2010

Hemophiliacs, hepatitis and HIV: A magic cure gone wrong

The dark side of capitalism’s effect on the medical and pharmaceutical industries is chillingly exposed in Doctor Guilt? Benefits of Medical Treatment Compared with Hazards – A tradeoff (published by iUniverse), the provocative new nonfiction by Everett Winslow Lovrien, M.D.

28 Oct 2010

Caliper Life Sciences third quarter GAAP revenue decreases 8% to $29.7 million

Caliper Life Sciences, Inc., today reported results for its third quarter ended September 30, 2010. Third quarter GAAP revenue decreased 8% to $29.7 million from $32.2 million in the same period in 2009 as a result of divestitures in 2010 and 2009. Revenue from on-going business increased 10% on a reported basis and 11% on an organic basis.

28 Oct 2010

POZEN reports net loss of $8.6M for third quarter 2010 vs. net income of $6.7M for third quarter 2009

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the third quarter ended September 30, 2010.

28 Oct 2010

First Edition: October 28, 2010

Today's news includes headlines about the reasons behind rising health premiums.

28 Oct 2010

AACN joins call for system-wide programs for medication reconciliation

The American Association of Critical-Care Nurses (AACN) added its bold voice to hospital healthcare leaders by endorsing a white paper that calls for system-wide programs for medication reconciliation — the process of verifying that current patient medications are correct, medically safe and necessary.

28 Oct 2010

New oncology training program for registered nurses in Ghana

The National Cancer Coalition (NCC) and the Ghana based organization Breast Care International (BCI) are pleased to announce the successful implementation of their oncology training program for registered nurses in Ghana. The program was officially sponsored by the US headquartered Johnson & Johnson and focuses on early detection of breast and cervical cancers for improved survival outcomes.

28 Oct 2010

RExpert to discuss latest advancements in musculoskeletal bioengineering at NCKU International Symposium

The 4th International Symposium and Workshop on Virtual Interactive Musculoskeletal System, organized by National Cheng Kung University, Taiwanese Society of Biomechanics and Taiwanese Society of Biomechanics in Sports, is held on October 28th and 29th in International Conference Hall, Kuang-Fu Campus, National Cheng Kung University (NCKU), Tainan, Taiwan,

28 Oct 2010

CECOLFES fertility treatment results demonstrate effectiveness of INVOcell cycle process

INVO Bioscience, Inc., a medical device company focused on treatment options for patients diagnosed with infertility, announced today that Dr. Elkin Lucena of the Columbian Fertility and Sterility Center (CECOLFES LTDA) in Bogota, Colombia presented the results of the Center's first 95 fertility treatment cycles utilizing INVO Bioscience's INVOcell for couples with fertility issues at the 66th Annual Meeting of the American Society of Reproductive Medicine (ASRM) in Denver.

28 Oct 2010

Future of health reform legislation and voting for Congressional elections

A comprehensive review of national opinion polls, including newly released data, shows that those who say they intend to vote for a Democratic congressional candidate in 2010 and those who say they intend to vote for a Republican in their district hold starkly different views of what they want the future of health reform legislation to be, mirroring the divide between Democratic and Republican leaders in Congress on this issue.

28 Oct 2010

Researchers explore knowledge of palliative care oncologists with respect to genetic testing

If you were dying from cancer, would you consider genetic testing. A recent study conducted by researchers from Virginia Commonwealth University Massey Cancer Center showed that most terminally ill cancer patients who were eligible for genetic testing never received it despite that it could potentially save a relative's life.

28 Oct 2010